-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on NOV, Raises Price Target to $21

Benzinga·10/29/2026 15:21:39
Listen to the news
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $20 to $21.